Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients

Bibliographic Details
Main Authors: Angelo Maiolino, Elaine Sobral Da Costa, Alberto Orfao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1211935/full
_version_ 1797822284696649728
author Angelo Maiolino
Angelo Maiolino
Elaine Sobral Da Costa
Alberto Orfao
author_facet Angelo Maiolino
Angelo Maiolino
Elaine Sobral Da Costa
Alberto Orfao
author_sort Angelo Maiolino
collection DOAJ
first_indexed 2024-03-13T10:05:41Z
format Article
id doaj.art-b024ffe8ebb94507bd8254d7a4f46219
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-13T10:05:41Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b024ffe8ebb94507bd8254d7a4f462192023-05-22T13:33:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-05-011310.3389/fonc.2023.12119351211935Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patientsAngelo Maiolino0Angelo Maiolino1Elaine Sobral Da Costa2Alberto Orfao3Department of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilDepartment of Hematology, Instituto Americas de Ensino, Pesquisa e Inovação, Rio de Janeiro, BrazilDepartment of Internal Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilTranslational and Clinical Research Program, Cancer Research Center (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS) Institute for Biomedical Research of Salamanca (IBASAL), CIBERONC and Department of Medicine, University of Salamanca, Salamanca, Spainhttps://www.frontiersin.org/articles/10.3389/fonc.2023.1211935/fullminimal residual diseasemultiple myelomaprognostic factordisease monitoringflow cytometry
spellingShingle Angelo Maiolino
Angelo Maiolino
Elaine Sobral Da Costa
Alberto Orfao
Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
Frontiers in Oncology
minimal residual disease
multiple myeloma
prognostic factor
disease monitoring
flow cytometry
title Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
title_full Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
title_fullStr Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
title_full_unstemmed Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
title_short Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
title_sort editorial minimal residual disease mrd assessment in multiple myeloma patients
topic minimal residual disease
multiple myeloma
prognostic factor
disease monitoring
flow cytometry
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1211935/full
work_keys_str_mv AT angelomaiolino editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients
AT angelomaiolino editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients
AT elainesobraldacosta editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients
AT albertoorfao editorialminimalresidualdiseasemrdassessmentinmultiplemyelomapatients